News
05-05-2011, 07:00 AM
CytRx Corporation, a biopharmaceutical company specializing in oncology, today reported financial results for the three months ended March 31, 2011, and provided a business update.
More... (http://www.news-medical.net/news/20110505/CytRx-reports-2463-million-net-loss-for-first-quarter-2011.aspx)
More... (http://www.news-medical.net/news/20110505/CytRx-reports-2463-million-net-loss-for-first-quarter-2011.aspx)